The NHS Bowel cancer screening programme achieves the anticipated survival improvement, but participation must be improved. Issue 2 (12th March 2018)

• Record Type: Journal Article
• Authors: Borowski, David W.; Cawkwell, Sarah; Zaidi, Syed M. Amir; Toward, Matthew; Maguire, Nicola; Garg, Dharmendra K.; Gill, Talvinder S.
• Is Part Of: International journal of health care quality assurance. Volume 31:Issue 2(2018)
• Page Start: 106
• Page End: 115
• Publication Date: 2018-03-12
• Subjects: Evidence-based practice -- Outcome -- Care pathways -- Colorectal cancer -- National health service -- Cancer screening; Medical care -- Quality control -- Periodicals; 362.1068
• DOI: 10.1108/IJHCQA-11-2016-0169
• Languages: English
• ISSNs: 0952-6862

Abstract

Abstract : Purpose: The NHS Bowel cancer screening programme (NHSBCSP) aims to reduce colorectal cancer (CRC) cumulative mortality by up to 23 per cent; long-term outcomes at national level are not yet known. The purpose of this paper is to examine a local population of CRC patients of screening age for their characteristics and long-term survival in relation to their presentation, including through the NHSBCSP. Design/methodology/approach: Retrospective analysis of a prospectively maintained CRC database for the years 2009-2014 in a single district hospital providing bowel cancer screening and tertiary rectal cancer services. Findings: Of 528 CRC patients diagnosed in the screening age range, 144(27.3 per cent) presented through NHSBCSP, 308(58.3 per cent) electively with symptoms and 76(14.4 per cent) as emergency. NHSBCSP-diagnosed patients were younger (median 66 vs 68 and 69 years, respectively, p =0.001), had more often left-sided cancers (59(41.0 per cent) vs 82(26.6 per cent) and 24(31.6 per cent), respectively, p =0.001), more UICC-stage I (42(29.2 per cent) vs 49(15.9 per cent) and 2(2.6 per cent)), stage III (59(41.0 per cent) vs 106(34.4 per cent) and 20(26.3 per cent)) and less stage IV disease (8(5.6 per cent) vs 61(19.8 per cent) and 34 (44.7 per cent), respectively, p <0.001). Three-year overall survival was best for NHSBCSP and worst for emergency patients (87.5 per cent vs 69.0 per cent and 35.3 per cent, respectively, LogRank p <0.001). Originality/value: Patients diagnosed within the NHSBCSP have improved outcome compared to both symptomatic elective and emergency presentations. A reduction in overall cumulative mortality in order of 25 per cent may well be achieved, but continuing high levels of emergency presentations and undetected right-sided disease emphasise need for further improvement in public participation in the NHSBCSP and research into more sensitive and acceptable alternative screening methods.